179 related articles for article (PubMed ID: 36139736)
1. Full Regression of Peyronie's Disease Plaque Following Combined Antioxidant Treatment: A Three-Case Report.
Paulis G; De Giorgio G
Antioxidants (Basel); 2022 Aug; 11(9):. PubMed ID: 36139736
[TBL] [Abstract][Full Text] [Related]
2. Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series.
Paulis G; De Giorgio G
J Med Case Rep; 2022 Oct; 16(1):359. PubMed ID: 36207748
[TBL] [Abstract][Full Text] [Related]
3. Complete Plaque Regression in Patients with Peyronie's Disease After Multimodal Treatment with Antioxidants: A Report of 2 Cases.
Paulis G; De Giorgio G
Am J Case Rep; 2022 Apr; 23():e936146. PubMed ID: 35430575
[TBL] [Abstract][Full Text] [Related]
4. Disappearance of Plaque Following Treatment with Antioxidants in Peyronie's Disease Patients-A Report of 3 Cases.
Paulis G; De Giorgio G
Clin Pract; 2022 Dec; 12(6):1020-1033. PubMed ID: 36547113
[TBL] [Abstract][Full Text] [Related]
5. Review of Management Options for Patients With Atypical Peyronie's Disease.
Yafi FA; Hatzichristodoulou G; DeLay KJ; Hellstrom WJ
Sex Med Rev; 2017 Apr; 5(2):211-221. PubMed ID: 27544298
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study.
Paulis G; Barletta D; Turchi P; Vitarelli A; Dachille G; Fabiani A; Gennaro R
Res Rep Urol; 2016; 8():1-10. PubMed ID: 26770906
[TBL] [Abstract][Full Text] [Related]
7. Surgical Outcomes of Plaque Excision and Grafting and Supplemental Tunica Albuginea Plication for Treatment of Peyronie's Disease With Severe Compound Curvature.
Chow AK; Sidelsky SA; Levine LA
J Sex Med; 2018 Jul; 15(7):1021-1029. PubMed ID: 29802005
[TBL] [Abstract][Full Text] [Related]
8. The treatment of loss of penile rigidity associated with Peyronie's disease.
Krane RJ
Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
[TBL] [Abstract][Full Text] [Related]
9. Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application.
Paulis G; Paulis A; Romano G; Barletta D; Fabiani A
Res Rep Urol; 2017; 9():129-139. PubMed ID: 28791261
[TBL] [Abstract][Full Text] [Related]
10. Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
Goldstein I; McLane MP; Xiang Q; Wolfe HR; Hu Y; Gelbard MK
Urology; 2020 Dec; 146():145-151. PubMed ID: 32896582
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
Paulis G; Brancato T
Inflamm Allergy Drug Targets; 2012 Feb; 11(1):48-57. PubMed ID: 22309083
[TBL] [Abstract][Full Text] [Related]
12. Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study.
Paulis G; Cavallini G; Brancato T; Alvaro R
Inflamm Allergy Drug Targets; 2013 Feb; 12(1):61-7. PubMed ID: 23004005
[TBL] [Abstract][Full Text] [Related]
13. Could plaque excision surgery with sis graft induce a new fibrotic reaction in la Peyronie's disease patients?
Rolle L; Tamagnone A; Bollito E; Ceruti C; Timpano M; Negro CL; Galletto E; Fontana D
Arch Ital Urol Androl; 2007 Dec; 79(4):167-9. PubMed ID: 18303735
[TBL] [Abstract][Full Text] [Related]
14. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Oral Pentoxifylline, Colchicine, and Penile Traction for the Management of Peyronie's Disease.
Ibrahim A; Gazzard L; Alharbi M; Rompré-Brodeur A; Aube M; Carrier S
Sex Med; 2019 Dec; 7(4):459-463. PubMed ID: 31445974
[TBL] [Abstract][Full Text] [Related]
16. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
[TBL] [Abstract][Full Text] [Related]
17. Management of Peyronie's disease--a review.
Tunuguntla HS
World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Review of Grafting Techniques for the Surgical Treatment of Peyronie's Disease.
Hatzichristodoulou G; Osmonov D; Kübler H; Hellstrom WJG; Yafi FA
Sex Med Rev; 2017 Oct; 5(4):544-552. PubMed ID: 28258933
[TBL] [Abstract][Full Text] [Related]
19. Clinical Presentation of Peyronie's Disease: A Retrospective Study of 564 Cases.
Paulis G; De Giorgio G; Paulis A
Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893650
[TBL] [Abstract][Full Text] [Related]
20. Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie's disease.
Gannon MK; Pearlman AM
BMC Urol; 2021 Jun; 21(1):94. PubMed ID: 34176473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
